New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

Today's Free Fly Stories
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | all day >>
16:14 EDTEXAExa Corp. reports Q1 non-GAAP EPS (10c), consensus (12c)
Reports Q1 revenue $14.8M, consensus $14.65M.
16:14 EDTBOBEBob Evans to pursue monetization of headquarters and two facilities
Subscribe for More Information
16:13 EDTDECKDeckers Outdoor rises 4.6% to $74.50 following Q4 report, FY16 outlook
Subscribe for More Information
16:13 EDTHAWKP2 Capital Partners reports 3.2% stake in Blackhawk
16:13 EDTDECKDeckers Outdoor sees FY16 reported EPS $5.09, consensus $5.05
Subscribe for More Information
16:13 EDTEXPOExponent announces two-for-one stock split
Subscribe for More Information
16:12 EDTVEEVVeeva raises FY16 EPS view to 45c-46c from 43c-45c, consensus 44c
Raises FY16 revenue view to $393M-$397M from $390M-$295M, consensus $395.22M.
16:12 EDTSPWHSportsman's Warehouse reports Q1 SSS down 0.7%
Subscribe for More Information
16:11 EDTSPWHSportsman's Warehouse sees FY15 EPS 56c-63c, consensus 61c
Subscribe for More Information
16:11 EDTHRTXHeron Therapeutics announces positive results from Phase 3 MAGIC study of Sustol
Heron Therapeutics announced positive, top-line results from its recently completed Phase 3 MAGIC study. MAGIC evaluated the efficacy and safety of the Company’s 5-HT3 receptor antagonist product candidate Sustol as part of a three-drug regimen with the intravenous neurokinin-1 receptor antagonist fosaprepitant and the IV corticosteroid dexamethasone for the prevention of delayed-onset chemotherapy-induced nausea and vomiting following administration of highly emetogenic chemotherapy agents. The MAGIC study is the only Phase 3 CINV prophylaxis study in a HEC population performed to-date to use as a comparator the currently recommended, standard-of-care, three-drug regimen: a 5-HT3 receptor antagonist, fosaprepitant and dexamethasone. The study was conducted entirely in the U.S. and enrolled over 900 patients undergoing HEC treatment for various tumor types. The primary endpoint in this study was the proportion of patients who achieved a Complete Response, defined as no emesis and no rescue medications during the delayed-onset phase of CINV, occurring 24-120 hours following administration of HEC agents. The study’s major efficacy findings include: The study’s primary endpoint was achieved. The percentage of patients who achieved a Complete Response was significantly higher in the Sustol group than the comparator group (64.7% vs. 56.6%, p=0.014).
16:11 EDTVEEVVeeva sees Q2 non-GAAP EPS 11c, consensus 11c
Subscribe for More Information
16:10 EDTDECKDeckers Outdoor sees Q1 EPS ($1.52), consensus ($1.17)
Subscribe for More Information
16:10 EDTSPWHSportsman's Warehouse sees Q2 EPS 11c-13c, consensus 14c
Sees Q2 revenue $167M-$172M, consensus $173.63M. Sees Q2 SSS in the range of (1.0%) to 1.0%.
16:10 EDTVEEVVeeva reports Q1 non-GAAP EPS 12c, consensus 10c
Subscribe for More Information
16:09 EDTDECKDeckers Outdoor reports Q4 EPS 4c, consensus 0c
Subscribe for More Information
16:09 EDTUNXL, QUIKUniPixel CFO Jeff Tomz to depart, Christine Russell appointed as CFO
UniPixel (UNXL) has appointed Christine Russell as CFO, succeeding Jeff Tomz who will continue in the role of director of finance for the next 30 days to assist with the transition. Russell previously served as CFO of Vendav. Russell currently serves as director and audit committee chair of QuickLogic (QUIK).
16:08 EDTKATEKate Spade initiated with a Perform at Oppenheimer
Subscribe for More Information
16:08 EDTGMEGameStop up 9% following beat and raise quarter
Subscribe for More Information
16:08 EDTBLOXInfoblox sees Q4 non-GAAP EPS 9c-10c, consensus 9c
Sees Q4 revenue $79M-$81M, consensus $78.39M.
16:07 EDTGMEGameStop raises FY15 EPS view to $3.63-$3.83 from $3.60-$3.80
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | all day >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use